STERIS plc (STE)
NYSE: STE · Real-Time Price · USD
235.70
-0.49 (-0.21%)
Oct 31, 2025, 4:00 PM EDT - Market closed
STERIS Employees
STERIS had 17,787 employees as of March 31, 2025. The number of employees decreased by 392 or -2.16% compared to the previous year.
Employees
17,787
Change (1Y)
-392
Growth (1Y)
-2.16%
Revenue / Employee
$313,213
Profits / Employee
$36,355
Market Cap
23.21B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 17,787 | -392 | -2.16% |
| Mar 31, 2024 | 18,179 | 1,079 | 6.31% |
| Mar 31, 2023 | 17,100 | 678 | 4.13% |
| Mar 31, 2022 | 16,422 | 3,652 | 28.60% |
| Mar 31, 2021 | 12,770 | 411 | 3.33% |
| Mar 31, 2020 | 12,359 | 359 | 2.99% |
| Mar 31, 2019 | 12,000 | 0 | - |
| Mar 31, 2018 | 12,000 | 0 | - |
| Mar 31, 2017 | 12,000 | -2,000 | -14.29% |
| Mar 31, 2016 | 14,000 | 6,400 | 84.21% |
| Mar 31, 2015 | 7,600 | 1,600 | 26.67% |
| Mar 31, 2014 | 6,000 | 0 | - |
| Mar 31, 2013 | 6,000 | 1,000 | 20.00% |
| Mar 31, 2012 | 5,000 | 0 | - |
| Mar 31, 2011 | 5,000 | 0 | - |
| Mar 31, 2010 | 5,000 | 0 | - |
| Mar 31, 2009 | 5,000 | -300 | -5.66% |
| Mar 31, 2008 | 5,300 | 200 | 3.92% |
| Mar 31, 2007 | 5,100 | 0 | - |
| Mar 31, 2006 | 5,100 | -150 | -2.86% |
| Mar 31, 2005 | 5,250 | 150 | 2.94% |
| Mar 31, 2004 | 5,100 | 0 | - |
| Mar 31, 2003 | 5,100 | 604 | 13.43% |
| Mar 31, 2002 | 4,496 | -91 | -1.98% |
| Mar 31, 2001 | 4,587 | -223 | -4.64% |
| Mar 31, 2000 | 4,810 | 66 | 1.39% |
| Mar 31, 1999 | 4,744 | 244 | 5.42% |
| Mar 31, 1998 | 4,500 | 500 | 12.50% |
| Mar 31, 1997 | 4,000 | 3,440 | 614.29% |
| Mar 31, 1996 | 560 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
STE News
- 2 days ago - STERIS Announces Dividend of $0.63 per share - GlobeNewsWire
- 10 days ago - STERIS to Host a Conference Call for Fiscal 2026 Second Quarter Results on November 6, 2025 - GlobeNewsWire
- 2 months ago - Steris: Marginal Gains Capitalized At Higher Rates, Reiterate Buy - Seeking Alpha
- 3 months ago - STERIS plc (STE) Q1 2026 Earnings Call Transcript - Seeking Alpha
- 3 months ago - STERIS Announces Chief Financial Officer Transition - GlobeNewsWire
- 3 months ago - STERIS Announces Financial Results for Fiscal 2026 First Quarter - GlobeNewsWire
- 3 months ago - STERIS Raises Dividend to $0.63 per share - GlobeNewsWire
- 3 months ago - STERIS to Host a Conference Call for Fiscal 2026 First Quarter Results on August 7, 2025 - GlobeNewsWire